BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

Clinical trial NCT01957735 · COMPLETED

Trial details

NCT number: NCT01957735
Sponsor: BPGbio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer Cancer Solid Tumor

Start date: 2013-10-01
Primary completion: 2017-02-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.